Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1321)
|
Core Tip (1331)
|
Full Article (HTML) (4413)
|
Full Article (PDF)-777K (684)
|
Audio-357K (37)
|
Peer-Review Report-122K (216)
|
Answering Reviewers-64K (267)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (12868)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications

World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1584)
|
Core Tip (1602)
|
Full Article (HTML) (14236)
|
Figures (1-4) (1932)
|
Full Article (PDF)-948K (1381)
|
Audio-1310K (34)
|
Peer-Review Report-106K (453)
|
Answering Reviewers-19K (306)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (63)
|
Total Visits (29532)
|
Similar Articles (505)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model

World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1453)
|
Core Tip (1451)
|
Full Article (HTML) (5360)
|
Figures (1-2) (417)
|
Tables (1-2) (398)
|
Full Article (PDF)-1246K (787)
|
Audio-442K (34)
|
Peer-Review Report-131K (389)
|
Answering Reviewers-120K (241)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (19805)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1336)
|
Core Tip (1338)
|
Full Article (HTML) (4321)
|
Figures (1-3) (423)
|
Tables (1-1) (414)
|
Full Article (PDF)-814K (585)
|
Audio-757K (32)
|
Peer-Review Report-105K (298)
|
Answering Reviewers-109K (264)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (18200)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1390)
|
Core Tip (1433)
|
Full Article (HTML) (4120)
|
Tables (1-3) (407)
|
Full Article (PDF)-799K (547)
|
Audio-1969K (25)
|
Peer-Review Report-132K (269)
|
Answering Reviewers-50K (236)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15724)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open